Table 2.
Baseline characteristics of the patients in different risk groups
| Characteristics | Freiburg cohort | Siena cohort | Leuven cohort | ||||||
|---|---|---|---|---|---|---|---|---|---|
| High risk | Low risk | P value | High risk | Low risk | P valve | High risk | Low risk | P value | |
| Age, years | 65.74 ± 10.06 | 69.06 ± 7.82 | 0.262 | 70.08 ± 11.34 | 67.28 ± 11.13 | 0.383 | 68.53 ± 7.80 | 67.97 ± 9.35 | 0.795 |
| ≥ 60 | 22 (71.0) | 27 (87.1) | 0.119 | 20 (80.0) | 22 (88.0) | 0.702 | 29 (90.6) | 27 (84.4) | 0.708 |
| < 60 | 9 (29.0) | 4 (12.9) | 5 (20.0) | 3 (12.0) | 3 (9.4) | 5 (15.6) | |||
| Gender | 1.000 | 0.480 | 0.120 | ||||||
| Female | 5 (16.1) | 4 (12.9) | 4 (16.0) | 6 (24.0) | 4 (12.5) | 9 (28.1) | |||
| Male | 26 (83.9) | 27 (87.1) | 21 (84.0) | 19 (76.0) | 28 (87.5) | 23 (71.9) | |||
| GAP | 0.027 | 0.051 | 0.080 | ||||||
| Stage I | 4 (12.9) | 13 (41.9) | 5 (20.0) | 9 (36.0) | 8 (25.0) | 17 (53.1) | |||
| Stage II | 18 (58.1) | 14 (45.2) | 8 (32.0) | 12 (48.0) | 19 (59.4) | 12 (37.5) | |||
| Stage III | 9 (29.0) | 4 (12.9) | 12 (48.0) | 4 (16.0) | 5 (15.6) | 3 (9.4) | |||
| Survival status | < 0.001 | 0.001 | 0.002 | ||||||
| Dead | 29 (93.5) | 16 (51.6) | 21 (84.0) | 10 (40.0) | 18 (56.3) | 6 (18.8) | |||
| Censored | 2 (6.5) | 15 (48.4) | 4 (16.0) | 15 (60.0) | 14 (43.7) | 26 (81.2) | |||
Values are presented as mean ± SD or n (%)
GAP gender, age and physiologic variables, SD standard deviation